Morgan Stanleyanalyst Stan Zlotsky downgraded Anaplan Inc. from Overweight to Equal-Weight and lowered the price target from $73 to $55, implying a 24 percent upside.
Zlotsky conducted another round of channel checks after the company’s Q3 earnings report, and the mixed checks suggest recent results “could be indicative of more prolonged challenges.”